US Food and Drug Administration (USFDA) has successfully completed its First inspection of SMS Lifesciences’ manufacturing facility located at Kazipally in the state of Telangana. The USFDA concluded the inspection with one Form 483 observation.
SMS Lifesciences India is engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, Active Pharmaceutical Ingredients (API) and Intermediates.
